Oral Genome

Diagnostic Equipment · Carlsbad, CA · Founded 2021 · Privately Held (backing)

Developer of oral health technology designed to identify potential dental health issues. Oral Genome is based in Carlsbad, CA and was founded in 2021. It was valued at $19.9 million at its early-stage round in Jan 2025, the last priced event on record. It has raised $4.4 million across 2 recorded rounds; the latest was a $3.1 million seed round in Jan 2025.

PMV mark · valuation
$19.9M
Oct 2026
Priced at
its early-stage round
Jan 2025
Total raised
$4.4M
Last round
Seed Round
Jan 2025

Oral Genome key facts

as of Oct 2026
  • Developer of oral health technology designed to identify potential dental health issues.
  • Oral Genome is valued at approximately $19.9M as of Oct 2026, set at its early-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $4.4M across 2 recorded rounds; the latest was Seed Round ($3.1M) in Jan 2025.
  • Notable investors include Plug and Play Tech Center, Springboard Enterprises, LvlUp Ventures, American Dental Association, Haleon — 9 tracked in total.
  • Oral Genome has filed 4 Form Ds with the SEC since 2021, most recently Jan 2025 ($3.1M sold to 37 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$19.9M

Valued at $19.9M at its early-stage round, Jan 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Oral Genome with a free account
  • ·Watch Oral Genome: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Oral Genome funding rounds

2 rounds
Jan 2025Seed Round$3.1MSEC filing▮
Sep 2022Accelerator/Incubator—▮

Oral Genome valuation

Oral Genome was valued at $19.9 million at its early-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Oral Genome raised?

Oral Genome has raised $4.4 million in total; 2 of its rounds are on record. The largest on record was a $3.1 million seed round in Jan 2025.

Oral Genome has filed 4 Form Ds with the SEC since 2021, most recently in Jan 2025 ($3.1 million sold to 37 investors).

Oral Genome investors

9 investors are on record for Oral Genome, including Plug and Play Tech Center, Springboard Enterprises, LvlUp Ventures and American Dental Association. The seed round in Jan 2025 drew 37 investors.

Comparable companies

Comparable diagnostic equipment names by valuation on PrivateMarketView: NanoMosaic ($85 million), AOA (Diagnostic Equipment) ($65 million) and WavelyDx ($11.3 million).

About Oral Genome

Developer of oral health technology designed to identify potential dental health issues. The company provides a dental testing kit that analyzes the oral microbiome and biomarkers affecting cavity and disease risk, enabling individuals to receive personalized recommendations and take preventive actions to improve oral health and reduce the likelihood of common dental problems.

Industry
Diagnostic Equipment
Sector
Healthcare
HQ
Carlsbad, CA, United States
Founded
2021
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.